As our study was a small cohort retrospective study and was not adjusted for other factors (e.g., starting dose of nal-IRI), further investigation is needed to determine the effect of UGT1A1*1/*28 or *1/*6 on neutropenia related to nal-IRI+5-FU/LV. Here, UGT1A1 is linked to neutropenia.